628 results on '"Lal, Altaf A."'
Search Results
2. Time series analysis of malaria cases to assess the impact of various interventions over the last three decades and forecasting malaria in India towards the 2030 elimination goals
3. Assessment of Plasmodium falciparum drug resistance associated molecular markers in Mandla, Madhya Pradesh, India
4. Sinococuline, a bioactive compound of Cocculus hirsutus has potent anti-dengue activity
5. Evaluation of the model malaria elimination strategy in Mandla district along with its neighbouring districts: a time series analysis from 2008 to 2020
6. A comparative assessment of the community frontline health workers for their knowledge and practices of malaria diagnosis and treatment in three contiguous districts Mandla, Balaghat, and Dindori of Madhya Pradesh, India
7. Clinical safety and pharmacokinetic evaluation of aqueous extract of Cocculus hirsutus, an anti-viral phytopharmacetical drug as a potential for the treatment of dengue and COVID-19
8. Significance of nested PCR testing for the detection of low-density malaria infection amongst febrile patients from the Malaria Elimination Demonstration Project in Mandla, Madhya Pradesh, India
9. Mass screening and treatment (MSaT) for identifying and treating asymptomatic cases of malaria-malaria elimination demonstration project (MEDP), Mandla, Madhya Pradesh
10. A qualitative study on community perceptions on quality of healthcare services they received in the Malaria Elimination Demonstration Project in district Mandla, India
11. Monitoring of the Village Malaria Workers to conduct activities of Malaria Elimination Demonstration Project in Mandla, Madhya Pradesh
12. Arterolane–piperaquine–mefloquine versus arterolane–piperaquine and artemether–lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a single-centre, open-label, randomised, non-inferiority trial
13. Dengue and Zika virus infections are enhanced by live attenuated dengue vaccine but not by recombinant DSV4 vaccine candidate in mouse models
14. Malaria elimination: situation analysis of cases in India, the state of Madhya Pradesh in central India, and district Mandla of Madhya Pradesh
15. Assessing community knowledge, attitude and practices to strengthen communication strategy for Malaria Elimination Demonstration Project in Mandla
16. Significance of training, monitoring and assessment of malaria workers in achieving malaria elimination goal of Malaria Elimination Demonstration Project
17. Assessment of ASHA for knowledge, diagnosis and treatment on malaria in Mandla district of Madhya Pradesh as part of the malaria elimination demonstration project
18. Socio-economic determinants of malaria in tribal dominated Mandla district enrolled in Malaria Elimination Demonstration Project in Madhya Pradesh
19. Improvement of Indoor Residual Spraying and Long‐Lasting Insecticidal Net services through structured monitoring and supervision as part of the Malaria Elimination Demonstration Project in Mandla, Madhya Pradesh
20. Malaria eradication within a generation: ambitious, achievable, and necessary
21. Science of malaria elimination: using knowledge of bottlenecks and enablers from the Malaria Elimination Demonstration Project in Central India for eliminating malaria in the Asia Pacific region
22. Time series analysis of malaria cases to assess the impact of various interventions over the last three decades and forecasting India’s malaria towards 2030 elimination goals
23. A Monkey's Tale: The Origin of Plasmodium vivax as a Human Malaria Parasite
24. Molecular Phylogeny and Evolutionary Relationships of Cryptosporidium Parasites at the Actin Locus
25. A study of malaria vector surveillance as part of the Malaria Elimination Demonstration Project in Mandla, Madhya Pradesh
26. Study design and operational framework for a community-based Malaria Elimination Demonstration Project (MEDP) in 1233 villages of district Mandla, Madhya Pradesh
27. Demonstration of indigenous malaria elimination through Track-Test-Treat-Track (T4) strategy in a Malaria Elimination Demonstration Project in Mandla, Madhya Pradesh
28. Evidence for Clonal Propagation in Natural Isolates of Plasmodium falciparum from Venezuela
29. Anti-Mosquito Midgut Antibodies Block Development of Plasmodium Falciparum and Plasmodium Vivax in Multiple Species of Anopheles Mosquitoes and Reduce Vector Fecundity and Survivorship
30. Molecular Characterization of a Cryptosporidium Isolate from a Black Bear
31. Immunogenicity and in vitro Protective Efficacy of a Recombinant Multistage Plasmodium falciparum Candidate Vaccine
32. The Evolution of Primate Malaria Parasites Based on the Gene Encoding Cytochrome b from the Linear Mitochondrial Genome
33. Plasmodium falciparum: Population Genetic Analysis by Multilocus Enzyme Electrophoresis and Other Molecular Markers
34. Genetic polymorphism and natural selection in the malaria parasite Plasmodium falciparum.
35. Efficacy of Grignard Pure to Inactivate Airborne Phage MS2, a Common SARS-CoV-2 Surrogate
36. Detection of the Cryptosporidium parvum "Human" Genotype in a Dugong (Dugong dugon)
37. 'Sinococuline, a bioactive compound of Cocculus hirsutus has potent anti-dengue activity’
38. The need for targeted implementation research to improve coverage of basic vaccines and introduction of new vaccines
39. The efficiency of Grignard Pure™ to inactivate airborne SARS-CoV-2 surrogate
40. Additional file 1 of Monitoring of the Village Malaria Workers to conduct activities of Malaria Elimination Demonstration Project in Mandla, Madhya Pradesh
41. Polymorphism of Fc Receptor IIa for Immunoglobulin G Is Associated with Placenta Malaria in HIV-1-Positive Women in Western Kenya
42. Treatment History and Treatment Dose Are Important Determinants of Sulfadoxine-Pyrimethamine Efficacy in Children with Uncomplicated Malaria in Western Kenya
43. Increased Efficacy of Sulfadoxine-Pyrimethamine in the Treatment of Uncomplicated Falciparum Malaria among Children with Sickle Cell Trait in Western Kenya
44. Fcγ Receptor IIa (CD32) Polymorphism Is Associated with Protection of Infants against High-Density Plasmodium falciparum Infection. VII. Asembo Bay Cohort Project
45. Identification of 5 Types of Cryptosporidium Parasites in Children in Lima, Peru
46. Immunity to Placental Malaria. II. Placental Antigen-Specific Cytokine Responses Are Impaired in Human Immunodeficiency Virus-Infected Women
47. Anti-Merozoite Surface Protein-1 19-kDa IgG in Mother-Infant Pairs Naturally Exposed to Plasmodium falciparum: Subclass Analysis with Age, Exposure to Asexual Parasitemia, and Protection against Malaria. V. The Asembo Bay Cohort Project
48. Effect of Immune Activation Induced by Cryptosporidium parvum Whole Antigen on in vitro Human Immunodeficiency Virus Type 1 Infection
49. In vivo Testing of Subunit Vaccines against Malaria Sporozoites Using a Rodent System
50. A Low Interleukin-10 Tumor Necrosis Factor-α Ratio Is Associated with Malaria Anemia in Children Residing in a Holoendemic Malaria Region in Western Kenya
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.